Cargando…
Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity
The global tuberculosis epidemic is the most common cause of death after infectious disease worldwide. Increasing numbers of infections with multi- and extensively drug-resistant variants of the Mycobacterium tuberculosis complex, resistant even to newly discovered and last resort antibiotics, highl...
Autores principales: | Schaible, Ulrich E., Linnemann, Lara, Redinger, Natalja, Patin, Emmanuel C., Dallenga, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732265/ https://www.ncbi.nlm.nih.gov/pubmed/29312298 http://dx.doi.org/10.3389/fimmu.2017.01755 |
Ejemplares similares
-
Evaluation of Myeloperoxidase as Target for Host-Directed Therapy in Tuberculosis In Vivo
por: Linnemann, Lara C., et al.
Publicado: (2022) -
Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity
por: Patin, Emmanuel C., et al.
Publicado: (2017) -
Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis
por: Schaible, Ulrich E., et al.
Publicado: (2018) -
Variation between Populations in the Innate Immune Response to Vaccine Adjuvants
por: Kollmann, Tobias R.
Publicado: (2013) -
Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)